Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Welch Allyn plans to shed roughly 10% of its global workforce, about 275 jobs, to compensate for the 2.3% medical device excise tax that goes into effect next year.
As the contentious patent battle between St. Jude Medical and Volcano Corp. over fractional flow reserve technology enters the critical claim construction phase, an analyst gives St. Jude a slight edge but says Volcano’s downside is manageable.
Gary Ellis, CFO of Medtronic, tells investors that the medical device company’s size and scale give it an edge in overcoming changes in the healthcare environment.